Related references
Note: Only part of the references are listed.Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis
A. Toczek et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis
M. T. Gler et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects
Ekaterina V. Kurbatova et al.
TUBERCULOSIS (2012)
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja et al.
PLOS MEDICINE (2012)
Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence
Jason E. Farley et al.
PLOS ONE (2011)
High Level of Cross-Resistance between Kanamycin, Amikacin, and Capreomycin among Mycobacterium tuberculosis Isolates from Georgia and a Close Relation with Mutations in the rrs Gene
Levan Jugheli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
James C. Johnston et al.
PLOS ONE (2009)
Multidrug-resistant tuberculosis
Ellen M. Zager et al.
BMC INFECTIOUS DISEASES (2008)
Meta-analysis of factors related to health services that predict treatment default by tuberculosis patients
Pedro Emmanuel Alvarenga Americano do Brasil et al.
Cadernos de Saude Publica (2008)
Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment
Molly F. Franke et al.
CLINICAL INFECTIOUS DISEASES (2008)
Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures
Helen S. Cox et al.
PLOS ONE (2007)
Multidrug-resistant tuberculosis in central Asia
HS Cox et al.
EMERGING INFECTIOUS DISEASES (2004)